1-10 of 10
R Pieters
Close
Sort by
Journal Articles

The Prognostic Value of JAK2 Exon 16 Mutations in Children with Down Syndrome and Acute Lymphoblastic Leukemia.

T. Buitenkamp, MSc, A. A. Danen-van Oorschot, PhD, M. Van Den Heuvel-Eibrink, MD, PhD, E. van Wering, R. Pieters, MD, PhD, C. M Zwaan, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1518.
https://doi.org/10.1182/blood.V112.11.1518.1518
Published: 2008
Journal Articles

Pharmacokinetics and Pharmacodynamics of High Dose Methotrexate in Children with Acute Lymphoblastic Leukemia and down Syndrome: a Case Cohort Study.

T. Buitenkamp, MSc, R. Mathot, A. Vulto, A. Veerman, MD, PhD, E. van Wering, R. Pieters, MD, PhD, M. Van Den Heuvel, MD, PhD, Christian M Zwaan, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1626.
https://doi.org/10.1182/blood.V112.11.1626.1626
Published: 2008
Journal Articles

Dasatinib (SPRYCEL®) in Children and Adolescents with Relapsed or Refractory Leukemia: Preliminary Results of the CA180018 Phase I/II Study from the ITCC Consortium.

Christian M. Zwaan, MD, M.L. den Boer, MD, H.B. Beverloo, V.H.J. van der Velden, J.M.A. Van Tornout, MD, D. Derreumaux, A. Baruchel, C. Rizzari, P. Kearns, R. Pieters
Journal: Blood
Blood (2007) 110 (11): 1049.
https://doi.org/10.1182/blood.V110.11.1049.1049
Published: 2007
Journal Articles

Prednisolone Resistance in Childhood Acute Lymphoblastic Leukemia: Vitro-Vivo Correlations and Cross-Resistance to Other Drugs

G.J.L. Kaspers, R. Pieters, C.H. Van Zantwijk, E.R. VanWering, A. Van Der Does-Van Den Berg, A.J.P. Veerman
Journal: Blood
Blood (1998) 92 (1): 259–266.
https://doi.org/10.1182/blood.V92.1.259.413k21_259_266
Published: 1998
Journal Articles

Relationship Between Major Vault Protein/Lung Resistance Protein, Multidrug Resistance-Associated Protein, P-Glycoprotein Expression, and Drug Resistance in Childhood Leukemia

M.L. den Boer, R. Pieters, K.M. Kazemier, M.M.A. Rottier, C.M. Zwaan, G.J.L. Kaspers, G. Janka-Schaub, G. Henze, U. Creutzig, R.J. Scheper, A.J.P. Veerman
Journal: Blood
Blood (1998) 91 (6): 2092–2098.
https://doi.org/10.1182/blood.V91.6.2092
Published: 1998
Journal Articles

In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia

G.J.L. Kaspers, A.J.P. Veerman, R. Pieters, C.H. Van Zantwijk, L.A. Smets, E.R. Van Wering, A. Van Der Does-Van Den Berg
Journal: Blood
Blood (1997) 90 (7): 2723–2729.
https://doi.org/10.1182/blood.V90.7.2723
Published: 1997
Journal Articles

In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia

E Klumper, R Pieters, AJ Veerman, DR Huismans, AH Loonen, K Hahlen, GJ Kaspers, ER van Wering, R Hartmann, G Henze
Journal: Blood
Blood (1995) 86 (10): 3861–3868.
https://doi.org/10.1182/blood.V86.10.3861.bloodjournal86103861
Published: 1995
Journal Articles

Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study

GJ Kaspers, LA Smets, R Pieters, CH Van Zantwijk, ER Van Wering, AJ Veerman
Journal: Blood
Blood (1995) 85 (3): 751–756.
https://doi.org/10.1182/blood.V85.3.751.bloodjournal853751
Published: 1995
Journal Articles

Expression of 5'-nucleotidase (CD73) related to other differentiation antigens in leukemias of B-cell lineage

R Pieters, LF Thompson, GJ Broekema, DR Huismans, GJ Peters, ST Pals, E Horst, K Hahlen, AJ Veerman
Journal: Blood
Blood (1991) 78 (2): 488–492.
https://doi.org/10.1182/blood.V78.2.488.488
Published: 1991
Journal Articles

In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions

R Pieters, AH Loonen, DR Huismans, GJ Broekema, MW Dirven, MW Heyenbrok, K Hahlen, AJ Veerman
Journal: Blood
Blood (1990) 76 (11): 2327–2336.
https://doi.org/10.1182/blood.V76.11.2327.2327
Published: 1990